Study of Sarvanga Ksheera Kashaya Dhara in the management of Diabetic Peripheral Neuropathy and compare its efficacy with Sarvanga Takra Dhara.

A randomized open labelled clinical study of Sarvanga Ksheera Kashaya Dhara in the management of Diabetic Peripheral Neuropathy and compare its efficacy with Sarvanga Takra Dhara. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102703

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G64- Other disorders of peripheral nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subject of age group between 30-65 years irrespective of occupation and socio - economic status. 2) Subjects of either gender who are suitable for Drava Sweda. 3) Diagnosed with Type 2 Diabetes Mellitus with clinical symptoms of DPN. 4) Subjects having history of uncontrolled long standing type 2 DM with RBS greater than or equal to 300. 5) Subjects who are willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects diagnosed with Type 1 Diabetes Mellitus. 2. Pregnant and lactating women. 3. Subjects presenting with diabetic foot ulcers or severe infections. 4. Individuals with local or systemic disorders that may interfere with the course of treatment.

Design outcomes

Primary

Measure	Time frame
Significant improvement in the symptoms of DPN with measurable difference between Sarvanga Ksheera Kashaya Dhara and Sarvanga Takra Dhara assessed through subjective parameters and objective parameters. Timepoint: Trial period: 7 days Assessment on: 0th day, 8th day Follow up:15th day Total study duration: 15 days	—

Secondary

Measure	Time frame
Generation of in depth analyzed data on the different aspect of the disease and procedure. Generation of data on possible unexpected or adverse drug reactions or events. Generation of data on quality of life with the test treatment modalities assessed based on Norfolk Quality of Life Diabetic Neuropathy.Timepoint: Trial period: 7 days Assessment on: 0th day, 8th day Follow up:15th day Total study duration: 15 days	—

Measure

Time frame

Generation of in depth analyzed data on the different aspect of the disease and procedure. Generation of data on possible unexpected or adverse drug reactions or events. Generation of data on quality of life with the test treatment modalities assessed based on Norfolk Quality of Life Diabetic Neuropathy.Timepoint: Trial period: 7 days Assessment on: 0th day, 8th day Follow up:15th day Total study duration: 15 days

—

Countries

India

Contacts

Public ContactDr Prarthana T

Sri Sri College Of Ayurvedic Science and Research hospital

drprarthana88@gmail.com9513180577

Outcome results